Creative Planning Raises Stock Holdings in Qiagen (NYSE:QGEN)

Creative Planning boosted its holdings in Qiagen (NYSE:QGEN) by 12.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 40,571 shares of the company’s stock after buying an additional 4,561 shares during the quarter. Creative Planning’s holdings in Qiagen were worth $1,849,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. GAMMA Investing LLC increased its position in shares of Qiagen by 806.5% during the 3rd quarter. GAMMA Investing LLC now owns 562 shares of the company’s stock valued at $26,000 after purchasing an additional 500 shares during the last quarter. Toronto Dominion Bank purchased a new stake in shares of Qiagen during the 2nd quarter valued at about $27,000. Park Place Capital Corp purchased a new stake in shares of Qiagen during the 1st quarter valued at about $36,000. Massmutual Trust Co. FSB ADV increased its position in shares of Qiagen by 39.8% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 853 shares of the company’s stock valued at $39,000 after purchasing an additional 243 shares during the last quarter. Finally, CWM LLC increased its position in shares of Qiagen by 12.0% during the 2nd quarter. CWM LLC now owns 2,505 shares of the company’s stock valued at $103,000 after purchasing an additional 269 shares during the last quarter. Hedge funds and other institutional investors own 70.00% of the company’s stock.

Qiagen Trading Up 0.6 %

Qiagen stock opened at $41.80 on Tuesday. Qiagen has a 12-month low of $34.74 and a 12-month high of $47.44. The company has a current ratio of 1.77, a quick ratio of 1.46 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $9.54 billion, a price-to-earnings ratio of 139.09, a P/E/G ratio of 3.17 and a beta of 0.39. The firm has a 50 day moving average of $44.58 and a 200 day moving average of $43.56.

Qiagen (NYSE:QGEN) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.03. Qiagen had a return on equity of 12.92% and a net margin of 3.75%. The business had revenue of $496.00 million during the quarter, compared to the consensus estimate of $495.45 million. During the same period in the prior year, the company posted $0.53 EPS. The firm’s revenue for the quarter was down .2% compared to the same quarter last year. As a group, research analysts predict that Qiagen will post 2.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on QGEN shares. HSBC lowered shares of Qiagen from a “buy” rating to a “hold” rating and set a $49.00 price target for the company. in a research report on Thursday, October 17th. Hsbc Global Res raised shares of Qiagen to a “hold” rating in a research report on Thursday, October 17th. Finally, Robert W. Baird upped their price target on shares of Qiagen from $49.00 to $52.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Five equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Qiagen has a consensus rating of “Moderate Buy” and a consensus target price of $50.12.

About Qiagen

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories.